Delcath Systems (DCTH) Liabilities and Shareholders Equity (2010 - 2026)
Delcath Systems' (DCTH) quarterly Liabilities and Shareholders Equity came in at $124.8 million in Q1 2026, up 42.97% year-on-year from $87.3 million in Q1 2025, and up 0.98% quarter-over-quarter from $123.6 million in Q4 2025.
Delcath Systems (DCTH) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Delcath Systems' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $124.8 million for Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 42.97% year-over-year to $124.8 million in Q1 2026; TTM through Mar 2026 was $489.6 million, a 113.35% increase from a year earlier, with the FY2025 full-year figure at $123.6 million, up 61.42% from the prior year.
- Liabilities and Shareholders Equity grew to $124.8 million in Q1 2026 per DCTH's latest filing, from $123.6 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $124.8 million in Q1 2026 and bottomed at $17.9 million in Q4 2022.
- The 5-year median for Liabilities and Shareholders Equity is $36.1 million (2024), against an average of $57.6 million.
- Across the five-year window, Liabilities and Shareholders Equity tumbled 46.08% in 2022 and jumped 292.33% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $17.9 million in 2022, then surged by 116.17% to $38.6 million in 2023, then soared by 98.35% to $76.6 million in 2024, then surged by 61.42% to $123.6 million in 2025, then gained by 0.98% to $124.8 million in 2026.
- Per Business Quant, the three latest DCTH Liabilities and Shareholders Equity figures stand at $124.8 million (Q1 2026), $123.6 million (Q4 2025), and $124.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 6.63 Bn |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 37.13 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 31.92 Bn |
| 10 | Delcath Systems | 429.73 Mn | 340.43 Mn | 21.26 Mn | 124.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.84 Mn |
| Dec 31, 2025 | 123.63 Mn |
| Sep 30, 2025 | 124.30 Mn |
| Jun 30, 2025 | 116.88 Mn |
| Mar 31, 2025 | 87.32 Mn |
| Dec 31, 2024 | 76.59 Mn |
| Sep 30, 2024 | 31.68 Mn |
| Jun 30, 2024 | 33.91 Mn |
| Mar 31, 2024 | 36.10 Mn |
| Dec 31, 2023 | 38.61 Mn |
| Sep 30, 2023 | 47.58 Mn |
| Jun 30, 2023 | 21.05 Mn |
| Mar 31, 2023 | 30.60 Mn |
| Dec 31, 2022 | 17.86 Mn |
| Sep 30, 2022 | 20.23 Mn |
| Jun 30, 2022 | 21.07 Mn |
| Mar 31, 2022 | 27.32 Mn |
| Dec 31, 2021 | 33.12 Mn |
| Sep 30, 2021 | 34.43 Mn |
| Jun 30, 2021 | 24.92 Mn |